Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.

Aptar Digital Health today announced survey findings showcasing the impact of its iPump connected assistant for medication ...

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS.

Retractable Technologies (NYSE:RVP) announced today that it reduced its workforce by approximately 7%. The Little Elm, ...

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

Howard Look announced that he is stepping down from his role as CEO at automated insulin delivery technology developer ...

A review of several studies highlighted the role smart infusion pump interoperability can play in medication administration.

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care.